Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
TRPV1-Tat is a peptide antagonist of transient receptor potential vanilloid 1 (TRPV1).1 It consists of amino acids 736-745 from the A-kinase anchor protein (AKAP)-binding domain of TRPV1 and the cell-penetrating peptide sequence from HIV Tat. TRPV1-Tat (200 µM) inhibits currents induced by heat or phorbol 12-myristate 13-acetate (PMA; Item No. 10008014) in whole-cell patch-clamp assays using primary mouse dorsal root ganglia. It increases the hind paw mechanical pain threshold in rats when administered at the doses 10 or 30 µM.2
WARNING This product is not for human or veterinary use.
1. Disrupting sensitization of transient receptor potential vanilloid subtype 1 inhibits inflammatory hyperalgesia. J. Neurosci. 33(17), 7407-7414 (2013).
2. Peripheral group I metabotropic glutamate receptor activation leads to muscle mechanical hyperalgesia through TRPV1 phosphorylation in the rat. J. Pain 16(1), 67-76 (2015).